Athersys (NASDAQ:ATHX) Now Covered by StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX) in a note issued to investors on Monday. The firm set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Price Performance

Athersys stock opened at $0.00 on Monday. The business has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.02. Athersys has a 52-week low of $0.01 and a 52-week high of $1.99. The company has a market cap of $283,907.40, a P/E ratio of 0.00 and a beta of -0.90.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.